4/22
Biology
First ever ‘pioneer’ factor found in plants enables cells to change their fate
To start the process of unpacking tightly bundled genetic material, plants depend on the LEAFY pioneer protein, according to work led by biologist Doris Wagner.
Climate change doesn’t spare the smallest
Changing conditions have taken a toll on insects in the tropics, according to research by School of Arts & Sciences biologists Daniel Janzen and Winnie Hallwachs. But education and science offer a path forward, they say.
One step closer to an at-home, rapid COVID-19 test
The lab of César de la Fuente is working on a paper-based biosensor that could provide results in minutes. Clinical trials began Jan. 5.
Novel anti-craving mechanism discovered to treat cocaine relapse
New research from School of Nursing has discovered that certain biological chemicals are expressed on specific cell types and neural circuits in the brain that reduce cocaine-seeking behavior.
Dynamic plants
Led by School of Arts & Sciences prof Brian Gregory and postdoc Xiang Yu, researchers have uncovered one way plants respond to hormonal cues. A similar process is likely at play in mammals.
Potential cellular target for eliminating bone breakdown in osteoporosis found
New research has discovered a cell type that governs the way bones form and maintain themselves, opening up a potential target for future therapies for bone disorders like osteoporosis.
Two Penn faculty named 2020 AAAS Fellows
Qi Long and E. Michael Ostap of the Perelman School of Medicine are among a cohort of 489 distinguished scientists recognized with the honor from the American Association for the Advancement of Science.
Customized kits turn students’ dining rooms into biology labs
Students in introductory biology laboratory courses in the School of Arts & Sciences used customized laboratory kits to get hands-on practice with the scientific method.
Donita Brady is ready for the next steps in cancer biology research
The Presidential Professor of cancer biology leads a team that is working to understand how cancer grows uncontrolled in cells and discovering novel ways to stop it.
Two key events that turn normal cells into cancer
The discovery of a unifying mechanism could inform new therapeutic approaches to prevent normal cells from transforming into any type of tumor.
In the News
When is the best time to take L-theanine—morning or night?
According to Colleen Tewksbury of the School of Nursing, research suggests that L-theanine may help support stress management, sleep, and potentially weight management.
FULL STORY →
Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
Scott Hensley of the Perelman School of Medicine is working on a flu vaccine to provide protection against 20 subtypes of flu that may pose a pandemic threat in the future.
FULL STORY →
Thanks, Neanderthals: How our ancient relatives could help find new antibiotics
A study by César de la Fuente of the Perelman School of Medicine and colleagues used AI to recreate molecules from ancient humans that could be potential candidates for antimicrobial treatments.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →
A crucial pattern behind long COVID may have been identified
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that several current hypotheses for the pathophysiology of long COVID are linked by a single pathway that is connected by serotonin reduction.
FULL STORY →